5-羟色胺能基因与SSRI类药物疗效的遗传药理学研究进展
摘要
本文就5-HT系统的基因多态性与SSRI类抗抑郁药物的疗效之间的关系作一综述。
出处
《精神医学杂志》
2009年第6期468-471,共4页
Journal of Psychiatry
参考文献21
-
1Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps : a STAR * D report [ J ]. Am J Psychiatry ,2006,163 ( 11 ) : 1905 - 1917.
-
2Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta - analysis of original data from 7 randomized controlled trials [ J ]. J Clin Psychiatry , 2005 ,66(8) :974 -981.
-
3Shishkina GT, Kalinina TS, Dygalo NN. Up - regulation of tryptophan hydroxylase -2 mRNA in the rat brain by chronic fluoxetine treatment correlates with its antidepressant effect [J]. Neuroscience, 2007 ,150(2) :404 -412.
-
4Serretti A, Zanardi R, Rossini D, et al. Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity[ J]. Mol Psychiatry ,2001 ,6 (5) : 586 - 592.
-
5Serretti A, Zanardi R, Cusin C, et al Tryptophan hydroxylase gene associated with paroxetine antidepressant activity [ J ]. Eur Neuropsychopharmacol ,2001,11 ( 5 ) :375 - 380.
-
6Ham B J, Lee BC, Paik JW, et al. Association between the tryptophan hydroxylase - 1 gene A218C pol):morphism and citalopram antidepressant response in a Korean population[ J ]. Prog Neuropsychopharmacol Biol Psychiatry , 2007 , 30; 31 (1) :104 - 107.
-
7Yoshida K, Naito S, Takahashi H, et al. Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder[ J]. Prog Neuropsychopharmacol Biol Psychiatry, 2002 ,26 (7 - 8) : 1279 - 1283.
-
8Durham LK, Webb SM, Milos PM, et al The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder[ J ]. Psychopharmacology (Berl) ,2004 , 174(4) :525 -529.
-
9Murphy GM, Jr. , Hollander SB, Rodrigues HE, et al. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression [ J ]. Arch Gen Psychiatry, 2004 , 61 (11) :1163 -1169.
-
10Hu XZ, Rush A J, Charney D, et al. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression [J]. Arch Gen Psychiatry, 2007 ,64(7) :783 -792.
二级参考文献8
-
1Oquendo MA,Mann JJ.The biology of impulsivity and suicidality[J].Psychiatr Clin North Am,2000,23:11-25.
-
2井上猛 小山司.难治性うっ病の治疗—ゎが国にぉける现状と治疗ァルゴリズム—[J].精神医学,1997,39:6-14.
-
3Yasuhiro Inayamo,Hiroshi Yoneda,Toshiaki Sakai,et al.Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia[J].Am J Med Gen (neuropsychiatric genetice),1996,67:103.
-
4井上猛,小山司. 三环系.四环系抗うっ药に治疗抵抗性うっ病の定义の妥当性に关する研究-第二选择の三环系.四环系抗うっ药への变更は有效な治疗战略か-[J].临床精神医学,1997,26:1603-1607.
-
5Yuan X,Yamada K,Ishiyama-Shigemoto S,et al.Identification of polymorphic Ioci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes[J].Diabetologia,2000,43:373-376.
-
6Marek GJ,Carpenter LL,McDougle CJ,et al.Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders[J].Neuropsychopharmacology,2003,28:402-412.
-
7张晓斌,张志珺,侯钢,姚辉,张心保,沙维伟.5-羟色胺2C受体基因启动子区多态性与迟发性运动障碍的关联分析[J].中华精神科杂志,2002,35(4):198-201. 被引量:7
-
8蔡军,陆峥,江三多,李霞,汪栋祥,姚培芬,熊祥玉.5-羟色胺2A受体基因多态性与抑郁症的关联[J].临床精神医学杂志,2004,14(3):129-130. 被引量:10
共引文献10
-
1钟盈花,瞿正万.难治性抑郁症的临床特征、发病机制及治疗研究进展[J].中华临床医师杂志(电子版),2012,6(19):5995-5996. 被引量:11
-
2施梅,刘薇,潘尚哈,毛晶,陈力.5-HT2c受体基因cys23ser多态性与单相抑郁症的相关性[J].中国行为医学科学,2007,16(7):586-588. 被引量:2
-
3郭明英,阿怀红.老年抑郁症发生的相关因素及护理进展[J].中国老年学杂志,2008,28(11):1137-1140. 被引量:2
-
4赵后锋,胡存昆,朱相华,耿德勤.5-羟色胺2C受体基因多态性与抑郁症的关联[J].临床精神医学杂志,2008,18(6):373-375. 被引量:2
-
5高婧,袁群,何国平.老年抑郁症的治疗护理新进展[J].中国老年学杂志,2009,29(24):3312-3314. 被引量:4
-
6曹金霞,张新建,耿德勤,姜建东.5-羟色胺2C受体基因-759C/T多态性与中国汉族脑卒中后抑郁的关系[J].临床神经病学杂志,2010,23(6):414-416. 被引量:2
-
7张延霞,张桂青.难治性抑郁症的发病机制研究现状[J].现代生物医学进展,2011,11(6):1194-1196. 被引量:9
-
8薄蔷,薛玲.5-HT_(2C)受体与抑郁症相关性研究进展[J].医学研究杂志,2012,41(6):5-7. 被引量:8
-
9马宏筠,葛红敏,毛稚霞,康明秀.米氮平合并氨磺必利或喹硫平治疗难治性抑郁症的对照研究[J].齐齐哈尔医学院学报,2013,34(18):2676-2677. 被引量:5
-
10池玉兰.老年抑郁症发生的相关因素[J].临床心身疾病杂志,2016,22(S1):384-385. 被引量:3
-
1张向红,朱晓玲,刘影刚.帕罗西汀与奥美拉唑治疗功能性消化不良31例治疗观察[J].辽宁医学杂志,2002,16(4):197-197.
-
2辛莉,覃逢超,王骏东.我院抗抑郁药应用分析[J].医学信息(下旬刊),2011,24(3):286-286.
-
3张芳英,杨继章,杨树民,张一民.2005~2008年我院新型抗抑郁药应用分析[J].中国医院用药评价与分析,2009,9(6):414-417. 被引量:12
-
4陈曼,严晓激,曲秦.SSRI类抗抑郁药物的进展[J].中国医药情报,2003,9(5):23-26.
-
5袁勇贵,张心保.新型抗抑郁药米氮平[J].中国新药与临床杂志,2001,20(3):219-221. 被引量:52
-
6喻东山,臧家平.氟西汀的不良反应和药物相互作用[J].医药导报,2005,24(10):900-902. 被引量:3
-
7高明,程文桃,林力,林涌超,莫夸耀,罗兰珠,郭少楠.新型抗抑郁药治疗抑郁症的对照研究[J].海峡药学,2014,26(4):89-91. 被引量:6
-
8徐俊冕.SSRI类抗抑郁药的临床应用经验[J].国外医药(合成药.生化药.制剂分册),2001,22(4):207-209. 被引量:22
-
9左津淮.米氮平的临床应用[J].天津药学,2004,16(6):53-56. 被引量:15
-
10杨军,段晓萍,包军,徐茂锦,苏定冯.孤束核神经元α肾上腺素能受体与5-羟色胺能受体的关系[J].第二军医大学学报,1993,14(4):356-359.